Esketamine-based intensified treatment or usual care after an initial treatment failure in depression
About this title
Read the official source — NCT05973851Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- Innsbruck and 11 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 418
- Sponsor
- Dr. Inge Winter
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United Kingdom, Austria, Germany, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05973851
- Official title
Show the full official title
A Randomised, Controlled Trial to Investigate the Effect of a Sixweek Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Recruitment & locations
Innsbruck, Austria · Bielefeld, Germany · Dortmund, Germany
9 more locations
- Frankfurt am Main, Germany
- Münster, Germany
- Athens, Greece
- Brescia, Italy
- Cagliari, Italy
- Naples, Italy
- Turin, Italy
- Barcelona, Spain
- London, United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Dr. Inge Winter.
Does this study involve medication?
Yes. The study involves medication, including Esketamine Nasal Product, Ketamine Hydrochloride, Esketamine hydrochloride and Second-line Antidepressants.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
